Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 58501 - 58525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Permethrin	Approved Investigational	CYP3A5	1577	upregulated	Permethrin results in increased expression of CYP3A5 mRNA	7q22.1	A23593
Permethrin	Approved Investigational	ESR1	2099	downregulated	Permethrin results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A21257
Permethrin	Approved Investigational	ESR1	2099	upregulated	Permethrin results in increased expression of ESR1 mRNA	6q25.1-q25.2	A21267
Permethrin	Approved Investigational	TFF1	7031	upregulated	Permethrin results in increased expression of TFF1 mRNA	21q22.3	A23595 A21257
Permethrin	Approved Investigational	WNT10B	7480	upregulated	Permethrin results in increased expression of WNT10B mRNA	12q13.12	A21392
Dinoprostone	Approved Investigational	ADM	133	downregulated	Dinoprostone results in decreased expression of ADM mRNA	11p15.4	A23596
Dinoprostone	Approved Investigational	AREG	374	upregulated	Dinoprostone results in increased expression of AREG mRNA	4q13.3	A21719 A23597
Dinoprostone	Approved Investigational	CCL17	6361	upregulated	Dinoprostone results in increased expression of CCL17 mRNA	16q21	A23598
Dinoprostone	Approved Investigational	CCL2	6347	downregulated	Dinoprostone results in decreased expression of CCL2 mRNA	17q12	A23598
Dinoprostone	Approved Investigational	CCL22	6367	upregulated	Dinoprostone results in increased expression of CCL22 mRNA	16q21	A23598
Dinoprostone	Approved Investigational	CCL3	6348	downregulated	Dinoprostone results in decreased expression of CCL3 mRNA	17q12	A23598
Dinoprostone	Approved Investigational	CCL4	6351	downregulated	Dinoprostone results in decreased expression of CCL4 mRNA	17q12	A23598
Dinoprostone	Approved Investigational	CCL5	6352	downregulated	Dinoprostone results in decreased expression of CCL5 mRNA	17q12	A23598
Dinoprostone	Approved Investigational	CCR5	1234	downregulated	Dinoprostone results in decreased expression of CCR5 mRNA	3p21.31	A23598
Dinoprostone	Approved Investigational	CCR7	1236	upregulated	Dinoprostone results in increased expression of CCR7 mRNA	17q21.2	A23598
Dinoprostone	Approved Investigational	COL1A1	1277	downregulated	Dinoprostone results in decreased expression of COL1A1 mRNA	17q21.33	A23599
Dinoprostone	Approved Investigational	CXCR4	7852	upregulated	Dinoprostone results in increased expression of CXCR4 mRNA	2q22.1	A23598
Dinoprostone	Approved Investigational	CYP11A1	1583	upregulated	Dinoprostone results in increased expression of CYP11A1 mRNA	15q24.1	A23600
Dinoprostone	Approved Investigational	CYP17A1	1586	upregulated	Dinoprostone results in increased expression of CYP17A1 mRNA	10q24.32	A23600
Dinoprostone	Approved Investigational	CYP19A1	1588	upregulated	Dinoprostone results in increased expression of CYP19A1 mRNA	15q21.2	A23601 A23600 A23602
Dinoprostone	Approved Investigational	CYP1B1	1545	upregulated	Dinoprostone results in increased expression of CYP1B1 mRNA	2p22.2	A23603
Dinoprostone	Approved Investigational	EREG	2069	upregulated	Dinoprostone results in increased expression of EREG mRNA	4q13.3	A23597
Dinoprostone	Approved Investigational	FOS	2353	upregulated	Dinoprostone results in increased expression of FOS mRNA	14q24.3	A20688
Dinoprostone	Approved Investigational	HSD3B2	3284	upregulated	Dinoprostone results in increased expression of HSD3B2 mRNA	1p12	A23600
Dinoprostone	Approved Investigational	IL12B	3593	upregulated	Dinoprostone results in increased expression of IL12B mRNA	5q33.3	A23604

Displaying entries 58501 - 58525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability